Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma

NCT00354107 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Anaplastic Large Cell Lymphoma
Recurrent Childhood Anaplastic Large Cell Lymphoma

Interventions

BIOLOGICAL: monoclonal antibody SGN-30
DRUG: therapeutic hydrocortisone
DRUG: ifosfamide
DRUG: carboplatin
DRUG: etoposide
DRUG: methotrexate
DRUG: cytarabine
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)